ABUS Market Cap History
Below is a table of the ABUS market cap history going back to 11/15/2010:

Date ABUS Market Cap
11/15/201072.78M
12/31/201048.59M
2/28/201151.19M
10/31/201120.65M
12/31/201118.22M
5/31/201230.10M
12/31/201270.95M
1/3/201370.80M
9/30/2013101.15M
2/28/2014406.58M
3/21/2014568.62M
5/8/2014256.31M
8/12/2014411.39M
10/30/2014378.00M
3/9/2015831.23M
4/30/2015838.85M
7/31/2015588.38M
10/31/2015300.13M
2/29/2016172.62M
4/30/2016270.40M
7/31/2016224.12M
10/31/2016172.75M
3/14/2017151.31M
4/30/2017187.08M
7/31/2017189.84M
10/31/2017311.04M
3/6/2018415.48M
4/30/2018449.37M
7/31/2018614.99M
10/31/2018235.22M
3/5/2019239.64M
4/30/2019152.93M
7/31/2019101.19M
10/31/201980.73M
3/2/2020196.48M
8/5/2020338.20M
11/5/2020243.69M
3/3/2021347.93M
5/3/2021331.57M
8/3/2021272.69M
11/2/2021531.61M
3/3/2022438.49M
5/3/2022359.92M
8/2/2022344.89M

Also see: ABUS Shares Outstanding History
and ABUS YTD Return
ABUS Historical Market Cap:
+14.20% CAGR
ABUS Historical Market Cap: +14.20% CAGR

Mouse over chart for data details
11/15/2010 ...8/2/2022
Arbutus Biopharma is a clinical-stage biopharmaceutical company utilizing its virology expertise to develop therapeutics that target specific viral diseases. Co.'s focus areas include Hepatitis B virus (HBV), SARS-CoV-2 and other coronaviruses. Co.'s product pipeline consists of the following programs: GalNAc RNAi, which is a subcutaneously-delivered RNA interference therapeutic targeted to hepatocytes; Oral Capsid Inhibitor, which is a capsid inhibitor; Oral PD-L1 Inhibitor, which is an oral PD-L1 inhibitor that has the potential to reawaken patients' HBV-specific immune response; and Oral HBV RNA Destabilizer, which is is Co.'s oral HBV specific RNA destabilizer. We show 44 historical shares outstanding datapoints in our ABUS shares outstanding history coverage, used to compute ABUS market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ABUS market cap history over the course of time is important for investors interested in comparing ABUS's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ABUS versus a peer is one thing; comparing ABUS market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ABUS can fluctuate over the course of history. With this page we aim to empower investors researching ABUS by allowing them to research the ABUS market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree ABUS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Arbutus Biopharma (ABUS) is categorized under the Miscellaneous sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ACAC Market Cap History
ACAH Market Cap History
ACAM Market Cap History
ACB Market Cap History
ACBA Market Cap History
ACEV Market Cap History
ACHR Market Cap History
ACIC Market Cap History
ACII Market Cap History
ACIU Market Cap History
More Miscellaneous companies »

 

ABUS Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.